Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$18.7M
3 rounds on record
Latest round
$8.7M
Venture round · Jan 2025 · 20 mo ago
Team
7
US Form 5500 (plan participants) · Dec 2025 · +17% in a year
Backers
1
AlleyCorp
The money's age
Due for its next round
20 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 15, 2025 Partnership Leucid Bio and Syenex Announce Strategic Collaboration for In Vivo CAR-T Cell Engineering · PRNewswire Jan 13, 2025 Raised a round Venture round $8.7M · SEC Form D Jan 9, 2025 Partnership CellFE and Syenex Collaborate to Advance Cell Engineering with Hybrid Gene Editing Workflow · YahooFinance Jun 1, 2022 Raised a round Venture round $5M · SEC Form D Jun 1, 2022 Raised a round Venture round $5M · SEC Form D 2022 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jan 2025 $8.7M — SEC Form D
Venture round Jun 2022 $5M — SEC Form D
Venture round Jun 2022 $5M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Syenex, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
John RosanelliExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Revolutionizing genomic medicines. Inspired by patients, directed by nature’s intelligence.
WhiteLab GenomicsFounded 2019 • 11-50 employees
Discover WhiteLab Genomics, where AI meets biology to revolutionize genomic medicine. Our innovative platform optimizes drug design for…
PhasegenomicsVenture round $4.8M · 3 yr ago • Founded 2015 • 11-50 employees
Phase Genomics: Fueling Genomic Discovery. CytoTerra® Cytogenetics, ProxiMeta™ Metagenome Deconvolution, Proximo™ Genome Scaffolding.
Ovation.ioSeries A $5M · 7 yr ago
Ovation is a genomic data company committed to unlocking the potential of human genomic data to accelerate precision medicine.
ChromaCode# Life Science/Healthcare# North AmericaVenture round $3.8M · 19 mo ago • Founded 2012 • 201-500 employees
ChromaCode is a leading provider of HDPCR™ multiplexing technology for genomic solutions. Our breakthrough platform enables labs…
KaryosoftFounded 2017
A genomics data science startup unifies all genomics data and connects it to life scientists through simple software solutions to drive…

Overview

Universal access to high quality delivery platforms for developers of genomics medicines. A new path for biotechnologists.

News

Press release PRNewswire 9 months ago
Leucid Bio and Syenex Announce Strategic Collaboration for In Vivo CAR-T Cell Engineering
/PRNewswire/ -- Leucid Bio ("Leucid" or the "Company"), a privately-held biotechnology company developing innovative Chimeric Antigen Receptor T-cell (CAR-T)...
Read more
Report
News FinanzNachrichten.de 9 months ago
Leucid Bio and Syenex Announce Strategic Collaboration for In Vivo CAR-T Cell Engineering
Enables in vivo delivery of LEU011 harnessing the VivoCell PlatformTMLONDON and CHICAGO, Dec. 15, 2025 /PRNewswire/ -- Leucid Bio ("Leucid" or the "Company"), a privately-held biotechnology
Read more
Report
News YahooFinance 1 year ago
ARTAN Bio Partners with Syenex VivoCell Platform for Precision in vivo Delivery of Next-Generation Codon Suppressors for Aging
ARTAN Bio, a community-backed biotechnology company developing therapeutics to reverse epigenetic changes associated with aging and age-related disease, and Syenex, an open-science genetic medicines platform company, today announced a strategic collaborat
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

People

John Rosanelli
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Evanston United States
HQ
50-200 est. staff

Financials

Total raised
$18.7M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $8.7M Details
Venture - Series Unknown 2022 $5M Details
Venture - Series Unknown 2022 $5M Details